• Oral Disorders Linked to SARS-CoV-2, Statin Use Increases Survival Rate, Abnormal Sodium Levels Predict Death Risk: COVID-19 Updates

    Clinical Research News I Repurposed arthritis drug falls short in Phase 3 clinical trial, optimal timing for donating convalescent plasma is within 60 days of symptom onset, most pregnant women and mothers report that they will vaccinate themselves and children, and only small percentage of COVID-19 patients suffer stroke, risk increases with age and CV risk factors. Plus: Clinicians warn of delayed injection-site reaction to Moderna vaccine for proper management and swollen salivary glands may be a common COVID-19 side effect.

    Mar 5, 2021

  • SCOPE 2021: New Players in Clinical Trials, AstraZeneca on RWE, Transcelerate Updates

    Clinical Research News | Day two of the Summit for Clinical Ops Executives (SCOPE) brings more updates from big pharma on the impacts of the COVID-19 pandemic, how AstraZeneca in deploying real-world evidence (RWE) in trials across broad therapeutic areas, and more.

    Mar 4, 2021

  • Medidata Named Winner of 2021 Participant Engagement Award

    Clinical Research News | Live at SCOPE yesterday, the winner of the 2021 Participant Engagement Award was chosen by a panel of judges. Patient Centricity by Design, a project from Medidata, was named the grand prize winner.

    Mar 3, 2021

  • SCOPE 2021: Pfizer, GSK’s Approach to COVID-19 Research, Patient Voice In Trials

    Clinical Research News | At the kickoff day for the Summit for Clinical Ops Executives 2021, teams from Pfizer talk vaccine development, Bayer, Pfizer, Abbvie and GSK report on the role of the patient in trial development, and GSK discusses the need for a “single source of truth” in pandemic response.

    Mar 3, 2021

  • Pandemic Highlights Value Of Remote Clinical Trials, Drug Repurposing

    Clinical Research News | A keynote address earlier this morning during opening ceremonies of the 2021 Summit for Clinical Ops Executives (SCOPE) offers glimmers of hope that the notoriously rigid clinical trial process may retain at least a few of the warp-speed changes introduced by the COVID-19 pandemic.

    Mar 2, 2021